Featured

Interview with Adam Low, CEO of SENTA Partners

Adam joined SENTA partners on May 6, 2019 as its Chief Executive Officer. In this role, Adam is responsible for the... Read more »

Alexandria Venture Investments Join $31 Million Seed Funding For Solu Therapeutics

BOSTON–(BUSINESS WIRE)–Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate... Read more »

Solu Therapeutics Closes of $31 Million Seed Funding

BOSTON--(BUSINESS WIRE)--Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate... Read more »

citybiz
Gain exposure through our multi-channel news platform.

2023’s States that Vaccinate the Most – WalletHub Study

Viveon Health Acquisition Corp. and Clearday to Merge

EmergeOrtho-Triangle Region Welcomes Dr. Rhett Hallows, Joint Replacement Surgeon

Labcorp to Acquire Outreach Laboratory Business

United Therapeutics Corporation Reports Second Quarter 2023 Financial Results

2023’s Best & Worst States for Health Care – WalletHub Study

RedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million

Inhibikase Therapeutics Announces a 1-for-6 Reverse Stock Split

Precision for Medicine Acquires Baseline Controls

Duos Raises $10 Million to Enable Older Adults Live Independently

Veralox Names PhaseBio’s Jonathan Mow as New CEO after Raising $24 Million

SV Health Investors Acquires Robling Medical

G1 Therapeutics Appoints Monica Thomas as General Counsel

EyePoint Pharmaceuticals Announces Sale of YUTIQ to Alimera Sciences for $82.5 Million Cash Plus Royalties

LifeNet Health Acquires Bioventus

Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion